What is Bioresorbable Vascular Scaffold?

A non-metallic mesh tube used to treat a narrowed artery; the new Bioresorbable Vascular Scaffold (BVS) is like a stent. Still, it dissolves steadily until the blocked artery can function normally again and remains open on its own. The BVS is created to help open a blocked artery in the heart and re-establish blood flow to the heart muscle, like a narrow mesh tube. Once the artery can remain open on its own, BVS eventually dissipates, possibly letting the blood vessel to function again naturally.

In appearance, Bioresorbable Vascular Scaffold is like a stent, but is a non-metallic, non-permanent, mesh implant that is eventually absorbed, dissolves over time and enables the artery to work again naturally, in the way a cast supports and then replaces a broken arm. Over 12-24 months, this new scaffold disappears and protects the vessel until it has the capacity and strength to remain open.

BVS is made of a material, such as dissolving stitches, that is widely used in other medical devices. This material helps the BVS to break down into elements like water (H2O) and carbon dioxide (CO2) that are already present in your body, allowing the artery to return to a more natural state.

BVS is the latest progress in treating Coronary Artery Disease.

You may not have a permanent implant that helps the artery restore a more normal function while treated with BVS.

BVS may help you in the following ways:

  • Eliminates the question about a permanent implant.
  • It helps you to resume your regular activities.
  • Your long-term cardiac health will have a positive effect.

It helps to decrease the risk of possible signs of coronary artery disease.

Effective blood thinners do not need to be provided for a long time, and natural vasomotor activity is restored as the stent disappears. The vessel is being taken back to normal again. It also helps to build a regular vessel, and it is possible to put bypass grafts in that region in the future if appropriate. Having an artery free of a permanent implant could mean that there are more options available if required to find the best care in the future.

Following the advent of metallic drug-eluting stents, this approach is seen as the 4th revolution in Interventional Cardiology. The new bioresorbable vascular scaffold approach is everolimus-eluting and offers transient vessel support with drug delivery capability, currently in drug-eluting stents, without the metal’s long-term limitations. This innovative technology also overcomes many metal stent-related safety issues and could also have more clinical benefits.

Another useful feature of BRS is that it permits for a non-invasive image without any significant image objects.

Comments are closed